BATS BZX Real-Time Price
As of 3:27pm ET
| -2.20 / -4.99%|
The 6 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 42.00, with a high estimate of 45.00 and a low estimate of 34.00. The median estimate represents a +0.24% increase from the last price of 41.90.
The current consensus among 6 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.